In regulatory news:

About a year after the CDC’s controversial opioid guidelines went into effect amid protests from a number of pain specialists, they have come under renewed scrutiny for having an allegedly unscientific basis. A recent study in Pain Medicine found that the federal review process used to justify the recommendations in the CDC guidelines was flawed. Holding studies on opioids to a higher standard of what constitutes a long-term study than that of other pain treatments, including anticonvulsant, antidepressant, nonsteroidal anti-inflammatory drugs (NSAIDs) and behavioral therapies, the study authors wrote, is “responsible for the disqualification of an entire literature” on the efficacy and effectiveness of opioids in managing chronic pain.

Read more via Pain Medicine News here.

Leave a Comment

Your email address will not be published. Required fields are marked *